Antibody to cytolethal distending toxin of Campylobacter jejuni
US10527621B2 · kind B2 · utility
2Cited by
25References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2018 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Nov 9, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes methods for preventing IBS, reducing the likelihood of developing IBS and/or treating IBS by administering CDT inhibitors and/or CDT neutralizers to a subject in need thereof. The present invention also describes methods of eliciting a specific immune response and methods of vaccinating a subject to prevent IBS or to reduce the likelihood of developing or having IBS. The present invention further describes methods of diagnosing IBS by detecting the presence or absence of CDT or a CDT marker in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.